Clinical and Radiologic Improvement following Tocilizumab Administration in Patients with SARS-CoV-2
Clinical Pulmonary Medicine
; 27(5):154-156, 2020.
Article
in English
| Scopus | ID: covidwho-972606
ABSTRACT
Cytokine release syndrome and acute respiratory distress syndrome are the major complications of coronavirus disease 2019 (COVID-19) and tocilizumab has shown efficacy in this setting. We report on 2 severely ill patients with COVID-19 treated with tocilizumab within 7 to 10 days of onset of symptoms. Tocilizumab markedly improved their clinical condition and was associated with regression of abnormalities on chest computed tomography within 1 week of tocilizumab administration. © 2020 Wolters Kluwer Health, Inc. All rights reserved.
Full text:
Available
Collection:
Databases of international organizations
Database:
Scopus
Type of study:
Prognostic study
Language:
English
Journal:
Clinical Pulmonary Medicine
Year:
2020
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS